Northwest Biotherapeutics(股票代碼NWBO)股價財報分析

Northwest Biotherapeutics, Inc. is a biotechnology company, which engages in the development of personalized immune therapies for cancer. It offers DCVax technology platform, which uses activated dendritic cells to mobilize a patient抯 own immune system to attack their cancer. The company was founded by Alton L. Boynton on March 18, 1996 and is headquartered in Bethesda, MD.

Northwest Biotherapeutics股票代碼NWBO,員工數量20人,成立日期:。



没有账号?注册  忘记密码?